Global Renal Diseases Drug Market Size, Status and Forecast 2021-2027
SKU ID : QYR-17744864 | Publishing Date : 19-Mar-2021
Detailed TOC of Global Renal Diseases Drug Market Size, Status and Forecast 2021-2027
1 Report Overview1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Renal Diseases Drug Market Size Growth Rate by Type: 2016 VS 2021 VS 2027
1.2.2 Chronic Kidney Disease (CKD) Drugs
1.2.3 End-Stage Kidney Disease (ESRD) Drugs
1.3 Market by Application
1.3.1 Global Renal Diseases Drug Market Share by Application: 2016 VS 2021 VS 2027
1.3.2 Hospitals
1.3.3 Specialty Clinics
1.3.4 Other
1.4 Study Objectives
1.5 Years Considered
2 Global Growth Trends
2.1 Global Renal Diseases Drug Market Perspective (2016-2027)
2.2 Renal Diseases Drug Growth Trends by Regions
2.2.1 Renal Diseases Drug Market Size by Regions: 2016 VS 2021 VS 2027
2.2.2 Renal Diseases Drug Historic Market Share by Regions (2016-2021)
2.2.3 Renal Diseases Drug Forecasted Market Size by Regions (2022-2027)
2.3 Renal Diseases Drug Industry Dynamic
2.3.1 Renal Diseases Drug Market Trends
2.3.2 Renal Diseases Drug Market Drivers
2.3.3 Renal Diseases Drug Market Challenges
2.3.4 Renal Diseases Drug Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Renal Diseases Drug Players by Revenue
3.1.1 Global Top Renal Diseases Drug Players by Revenue (2016-2021)
3.1.2 Global Renal Diseases Drug Revenue Market Share by Players (2016-2021)
3.2 Global Renal Diseases Drug Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Players Covered: Ranking by Renal Diseases Drug Revenue
3.4 Global Renal Diseases Drug Market Concentration Ratio
3.4.1 Global Renal Diseases Drug Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Renal Diseases Drug Revenue in 2020
3.5 Renal Diseases Drug Key Players Head office and Area Served
3.6 Key Players Renal Diseases Drug Product Solution and Service
3.7 Date of Enter into Renal Diseases Drug Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Renal Diseases Drug Breakdown Data by Type
4.1 Global Renal Diseases Drug Historic Market Size by Type (2016-2021)
4.2 Global Renal Diseases Drug Forecasted Market Size by Type (2022-2027)
5 Renal Diseases Drug Breakdown Data by Application
5.1 Global Renal Diseases Drug Historic Market Size by Application (2016-2021)
5.2 Global Renal Diseases Drug Forecasted Market Size by Application (2022-2027)
6 North America
6.1 North America Renal Diseases Drug Market Size (2016-2027)
6.2 North America Renal Diseases Drug Market Size by Type
6.2.1 North America Renal Diseases Drug Market Size by Type (2016-2021)
6.2.2 North America Renal Diseases Drug Market Size by Type (2022-2027)
6.2.3 North America Renal Diseases Drug Market Size by Type (2016-2027)
6.3 North America Renal Diseases Drug Market Size by Application
6.3.1 North America Renal Diseases Drug Market Size by Application (2016-2021)
6.3.2 North America Renal Diseases Drug Market Size by Application (2022-2027)
6.3.3 North America Renal Diseases Drug Market Size by Application (2016-2027)
6.4 North America Renal Diseases Drug Market Size by Country
6.4.1 North America Renal Diseases Drug Market Size by Country (2016-2021)
6.4.2 North America Renal Diseases Drug Market Size by Country (2022-2027)
6.4.3 United States
6.4.4 Canada
7 Europe
7.1 Europe Renal Diseases Drug Market Size (2016-2027)
7.2 Europe Renal Diseases Drug Market Size by Type
7.2.1 Europe Renal Diseases Drug Market Size by Type (2016-2021)
7.2.2 Europe Renal Diseases Drug Market Size by Type (2022-2027)
7.2.3 Europe Renal Diseases Drug Market Size by Type (2016-2027)
7.3 Europe Renal Diseases Drug Market Size by Application
7.3.1 Europe Renal Diseases Drug Market Size by Application (2016-2021)
7.3.2 Europe Renal Diseases Drug Market Size by Application (2022-2027)
7.3.3 Europe Renal Diseases Drug Market Size by Application (2016-2027)
7.4 Europe Renal Diseases Drug Market Size by Country
7.4.1 Europe Renal Diseases Drug Market Size by Country (2016-2021)
7.4.2 Europe Renal Diseases Drug Market Size by Country (2022-2027)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic
8 Asia-Pacific
8.1 Asia-Pacific Renal Diseases Drug Market Size (2016-2027)
8.2 Asia-Pacific Renal Diseases Drug Market Size by Type
8.2.1 Asia-Pacific Renal Diseases Drug Market Size by Type (2016-2021)
8.2.2 Asia-Pacific Renal Diseases Drug Market Size by Type (2022-2027)
8.2.3 Asia-Pacific Renal Diseases Drug Market Size by Type (2016-2027)
8.3 Asia-Pacific Renal Diseases Drug Market Size by Application
8.3.1 Asia-Pacific Renal Diseases Drug Market Size by Application (2016-2021)
8.3.2 Asia-Pacific Renal Diseases Drug Market Size by Application (2022-2027)
8.3.3 Asia-Pacific Renal Diseases Drug Market Size by Application (2016-2027)
8.4 Asia-Pacific Renal Diseases Drug Market Size by Region
8.4.1 Asia-Pacific Renal Diseases Drug Market Size by Region (2016-2021)
8.4.2 Asia-Pacific Renal Diseases Drug Market Size by Region (2022-2027)
8.4.3 China
8.4.4 Japan
8.4.5 South Korea
8.4.6 Southeast Asia
8.4.7 India
8.4.8 Australia
9 Latin America
9.1 Latin America Renal Diseases Drug Market Size (2016-2027)
9.2 Latin America Renal Diseases Drug Market Size by Type
9.2.1 Latin America Renal Diseases Drug Market Size by Type (2016-2021)
9.2.2 Latin America Renal Diseases Drug Market Size by Type (2022-2027)
9.2.3 Latin America Renal Diseases Drug Market Size by Type (2016-2027)
9.3 Latin America Renal Diseases Drug Market Size by Application
9.3.1 Latin America Renal Diseases Drug Market Size by Application (2016-2021)
9.3.2 Latin America Renal Diseases Drug Market Size by Application (2022-2027)
9.3.3 Latin America Renal Diseases Drug Market Size by Application (2016-2027)
9.4 Latin America Renal Diseases Drug Market Size by Country
9.4.1 Latin America Renal Diseases Drug Market Size by Country (2016-2021)
9.4.2 Latin America Renal Diseases Drug Market Size by Country (2022-2027)
9.4.3 Mexico
9.4.4 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Renal Diseases Drug Market Size (2016-2027)
10.2 Middle East & Africa Renal Diseases Drug Market Size by Type
10.2.1 Middle East & Africa Renal Diseases Drug Market Size by Type (2016-2021)
10.2.2 Middle East & Africa Renal Diseases Drug Market Size by Type (2022-2027)
10.2.3 Middle East & Africa Renal Diseases Drug Market Size by Type (2016-2027)
10.3 Middle East & Africa Renal Diseases Drug Market Size by Application
10.3.1 Middle East & Africa Renal Diseases Drug Market Size by Application (2016-2021)
10.3.2 Middle East & Africa Renal Diseases Drug Market Size by Application (2022-2027)
10.3.3 Middle East & Africa Renal Diseases Drug Market Size by Application (2016-2027)
10.4 Middle East & Africa Renal Diseases Drug Market Size by Country
10.4.1 Middle East & Africa Renal Diseases Drug Market Size by Country (2016-2021)
10.4.2 Middle East & Africa Renal Diseases Drug Market Size by Country (2022-2027)
10.4.3 Turkey
10.4.4 Saudi Arabia
10.4.5 UAE
11 Key Players Profiles
11.1 Pfizer
11.1.1 Pfizer Company Details
11.1.2 Pfizer Business Overview
11.1.3 Pfizer Renal Diseases Drug Introduction
11.1.4 Pfizer Revenue in Renal Diseases Drug Business (2016-2021)
11.1.5 Pfizer Recent Development
11.2 Amgen
11.2.1 Amgen Company Details
11.2.2 Amgen Business Overview
11.2.3 Amgen Renal Diseases Drug Introduction
11.2.4 Amgen Revenue in Renal Diseases Drug Business (2016-2021)
11.2.5 Amgen Recent Development
11.3 Roche
11.3.1 Roche Company Details
11.3.2 Roche Business Overview
11.3.3 Roche Renal Diseases Drug Introduction
11.3.4 Roche Revenue in Renal Diseases Drug Business (2016-2021)
11.3.5 Roche Recent Development
11.4 GlaxoSmithKline (GSK)
11.4.1 GlaxoSmithKline (GSK) Company Details
11.4.2 GlaxoSmithKline (GSK) Business Overview
11.4.3 GlaxoSmithKline (GSK) Renal Diseases Drug Introduction
11.4.4 GlaxoSmithKline (GSK) Revenue in Renal Diseases Drug Business (2016-2021)
11.4.5 GlaxoSmithKline (GSK) Recent Development
11.5 Allergan
11.5.1 Allergan Company Details
11.5.2 Allergan Business Overview
11.5.3 Allergan Renal Diseases Drug Introduction
11.5.4 Allergan Revenue in Renal Diseases Drug Business (2016-2021)
11.5.5 Allergan Recent Development
11.6 AbbVie
11.6.1 AbbVie Company Details
11.6.2 AbbVie Business Overview
11.6.3 AbbVie Renal Diseases Drug Introduction
11.6.4 AbbVie Revenue in Renal Diseases Drug Business (2016-2021)
11.6.5 AbbVie Recent Development
11.7 Kissei Pharmaceutical
11.7.1 Kissei Pharmaceutical Company Details
11.7.2 Kissei Pharmaceutical Business Overview
11.7.3 Kissei Pharmaceutical Renal Diseases Drug Introduction
11.7.4 Kissei Pharmaceutical Revenue in Renal Diseases Drug Business (2016-2021)
11.7.5 Kissei Pharmaceutical Recent Development
11.8 AstraZeneca
11.8.1 AstraZeneca Company Details
11.8.2 AstraZeneca Business Overview
11.8.3 AstraZeneca Renal Diseases Drug Introduction
11.8.4 AstraZeneca Revenue in Renal Diseases Drug Business (2016-2021)
11.8.5 AstraZeneca Recent Development
11.9 FibroGen
11.9.1 FibroGen Company Details
11.9.2 FibroGen Business Overview
11.9.3 FibroGen Renal Diseases Drug Introduction
11.9.4 FibroGen Revenue in Renal Diseases Drug Business (2016-2021)
11.9.5 FibroGen Recent Development
11.10 Sanofi
11.10.1 Sanofi Company Details
11.10.2 Sanofi Business Overview
11.10.3 Sanofi Renal Diseases Drug Introduction
11.10.4 Sanofi Revenue in Renal Diseases Drug Business (2016-2021)
11.10.5 Sanofi Recent Development
11.11 Teva Pharmaceutical Industries
11.11.1 Teva Pharmaceutical Industries Company Details
11.11.2 Teva Pharmaceutical Industries Business Overview
11.11.3 Teva Pharmaceutical Industries Renal Diseases Drug Introduction
11.11.4 Teva Pharmaceutical Industries Revenue in Renal Diseases Drug Business (2016-2021)
11.11.5 Teva Pharmaceutical Industries Recent Development
11.12 Johnson & Johnson
11.12.1 Johnson & Johnson Company Details
11.12.2 Johnson & Johnson Business Overview
11.12.3 Johnson & Johnson Renal Diseases Drug Introduction
11.12.4 Johnson & Johnson Revenue in Renal Diseases Drug Business (2016-2021)
11.12.5 Johnson & Johnson Recent Development
11.13 Keryx Biopharmaceuticals
11.13.1 Keryx Biopharmaceuticals Company Details
11.13.2 Keryx Biopharmaceuticals Business Overview
11.13.3 Keryx Biopharmaceuticals Renal Diseases Drug Introduction
11.13.4 Keryx Biopharmaceuticals Revenue in Renal Diseases Drug Business (2016-2021)
11.13.5 Keryx Biopharmaceuticals Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
List of Figures, Tables and Charts Available in Global Renal Diseases Drug Market Size, Status and Forecast 2021-2027
List of TablesTable 1. Global Renal Diseases Drug Market Size Growth Rate by Type (US$ Million):2016 VS 2021 VS 2027
Table 2. Key Players of Chronic Kidney Disease (CKD) Drugs
Table 3. Key Players of End-Stage Kidney Disease (ESRD) Drugs
Table 4. Global Renal Diseases Drug Market Size Growth by Application (US$ Million): 2016 VS 2021 VS 2027
Table 5. Global Renal Diseases Drug Market Size by Regions (US$ Million): 2016 VS 2021 VS 2027
Table 6. Global Renal Diseases Drug Market Size by Regions (2016-2021) & (US$ Million)
Table 7. Global Renal Diseases Drug Market Share by Regions (2016-2021)
Table 8. Global Renal Diseases Drug Forecasted Market Size by Regions (2022-2027) & (US$ Million)
Table 9. Global Renal Diseases Drug Market Share by Regions (2022-2027)
Table 10. Renal Diseases Drug Market Trends
Table 11. Renal Diseases Drug Market Drivers
Table 12. Renal Diseases Drug Market Challenges
Table 13. Renal Diseases Drug Market Restraints
Table 14. Global Renal Diseases Drug Revenue by Players (2016-2021) & (US$ Million)
Table 15. Global Renal Diseases Drug Market Share by Players (2016-2021)
Table 16. Global Top Renal Diseases Drug Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Renal Diseases Drug as of 2020)
Table 17. Ranking of Global Top Renal Diseases Drug Companies by Revenue (US$ Million) in 2020
Table 18. Global 5 Largest Players Market Share by Renal Diseases Drug Revenue (CR5 and HHI) & (2016-2021)
Table 19. Key Players Headquarters and Area Served
Table 20. Key Players Renal Diseases Drug Product Solution and Service
Table 21. Date of Enter into Renal Diseases Drug Market
Table 22. Mergers & Acquisitions, Expansion Plans
Table 23. Global Renal Diseases Drug Market Size by Type (2016-2021) (US$ Million)
Table 24. Global Renal Diseases Drug Revenue Market Share by Type (2016-2021)
Table 25. Global Renal Diseases Drug Forecasted Market Size by Type (2022-2027) (US$ Million)
Table 26. Global Renal Diseases Drug Revenue Market Share by Type (2022-2027) & (US$ Million)
Table 27. Global Renal Diseases Drug Market Size Share by Application (2016-2021) & (US$ Million)
Table 28. Global Renal Diseases Drug Revenue Market Share by Application (2016-2021)
Table 29. Global Renal Diseases Drug Forecasted Market Size by Application (2022-2027) (US$ Million)
Table 30. Global Renal Diseases Drug Revenue Market Share by Application (2022-2027) & (US$ Million)
Table 31. North America Renal Diseases Drug Market Size by Type (2016-2021) (US$ Million)
Table 32. North America Renal Diseases Drug Market Size by Type (2022-2027) & (US$ Million)
Table 33. North America Renal Diseases Drug Market Size by Application (2016-2021) (US$ Million)
Table 34. North America Renal Diseases Drug Market Size by Application (2022-2027) & (US$ Million)
Table 35. North America Renal Diseases Drug Market Size by Country (2016-2021) & (US$ Million)
Table 36. North America Renal Diseases Drug Market Size by Country (2022-2027) & (US$ Million)
Table 37. Europe Renal Diseases Drug Market Size by Type (2016-2021) (US$ Million)
Table 38. Europe Renal Diseases Drug Market Size by Type (2022-2027) & (US$ Million)
Table 39. Europe Renal Diseases Drug Market Size by Application (2016-2021) (US$ Million)
Table 40. Europe Renal Diseases Drug Market Size by Application (2022-2027) & (US$ Million)
Table 41. Europe Renal Diseases Drug Market Size by Country (2016-2021) & (US$ Million)
Table 42. Europe Renal Diseases Drug Market Size by Country (2022-2027) & (US$ Million)
Table 43. Asia-Pacific Renal Diseases Drug Market Size by Type (2016-2021) (US$ Million)
Table 44. Asia-Pacific Renal Diseases Drug Market Size by Type (2022-2027) & (US$ Million)
Table 45. Asia-Pacific Renal Diseases Drug Market Size by Application (2016-2021) (US$ Million)
Table 46. Asia-Pacific Renal Diseases Drug Market Size by Application (2022-2027) & (US$ Million)
Table 47. Asia-Pacific Renal Diseases Drug Market Size by Region (2016-2021) & (US$ Million)
Table 48. Asia-Pacific Renal Diseases Drug Market Size by Region (2022-2027) & (US$ Million)
Table 49. Latin America Renal Diseases Drug Market Size by Type (2016-2021) (US$ Million)
Table 50. Latin America Renal Diseases Drug Market Size by Type (2022-2027) & (US$ Million)
Table 51. Latin America Renal Diseases Drug Market Size by Application (2016-2021) (US$ Million)
Table 52. Latin America Renal Diseases Drug Market Size by Application (2022-2027) & (US$ Million)
Table 53. Latin America Renal Diseases Drug Market Size by Country (2016-2021) & (US$ Million)
Table 54. Latin America Renal Diseases Drug Market Size by Country (2022-2027) & (US$ Million)
Table 55. Middle East & Africa Renal Diseases Drug Market Size by Type (2016-2021) (US$ Million)
Table 56. Middle East & Africa Renal Diseases Drug Market Size by Type (2022-2027) & (US$ Million)
Table 57. Middle East & Africa Renal Diseases Drug Market Size by Application (2016-2021) (US$ Million)
Table 58. Middle East & Africa Renal Diseases Drug Market Size by Application (2022-2027) & (US$ Million)
Table 59. Middle East & Africa Renal Diseases Drug Market Size by Country (2016-2021) & (US$ Million)
Table 60. Middle East & Africa Renal Diseases Drug Market Size by Country (2022-2027) & (US$ Million)
Table 61. Pfizer Company Details
Table 62. Pfizer Business Overview
Table 63. Pfizer Renal Diseases Drug Product
Table 64. Pfizer Revenue in Renal Diseases Drug Business (2016-2021) & (US$ Million)
Table 65. Pfizer Recent Development
Table 66. Amgen Company Details
Table 67. Amgen Business Overview
Table 68. Amgen Renal Diseases Drug Product
Table 69. Amgen Revenue in Renal Diseases Drug Business (2016-2021) & (US$ Million)
Table 70. Amgen Recent Development
Table 71. Roche Company Details
Table 72. Roche Business Overview
Table 73. Roche Renal Diseases Drug Product
Table 74. Roche Revenue in Renal Diseases Drug Business (2016-2021) & (US$ Million)
Table 75. Roche Recent Development
Table 76. GlaxoSmithKline (GSK) Company Details
Table 77. GlaxoSmithKline (GSK) Business Overview
Table 78. GlaxoSmithKline (GSK) Renal Diseases Drug Product
Table 79. GlaxoSmithKline (GSK) Revenue in Renal Diseases Drug Business (2016-2021) & (US$ Million)
Table 80. GlaxoSmithKline (GSK) Recent Development
Table 81. Allergan Company Details
Table 82. Allergan Business Overview
Table 83. Allergan Renal Diseases Drug Product
Table 84. Allergan Revenue in Renal Diseases Drug Business (2016-2021) & (US$ Million)
Table 85. Allergan Recent Development
Table 86. AbbVie Company Details
Table 87. AbbVie Business Overview
Table 88. AbbVie Renal Diseases Drug Product
Table 89. AbbVie Revenue in Renal Diseases Drug Business (2016-2021) & (US$ Million)
Table 90. AbbVie Recent Development
Table 91. Kissei Pharmaceutical Company Details
Table 92. Kissei Pharmaceutical Business Overview
Table 93. Kissei Pharmaceutical Renal Diseases Drug Product
Table 94. Kissei Pharmaceutical Revenue in Renal Diseases Drug Business (2016-2021) & (US$ Million)
Table 95. Kissei Pharmaceutical Recent Development
Table 96. AstraZeneca Company Details
Table 97. AstraZeneca Business Overview
Table 98. AstraZeneca Revenue in Renal Diseases Drug Business (2016-2021) & (US$ Million)
Table 99. AstraZeneca Recent Development
Table 100. FibroGen Company Details
Table 101. FibroGen Business Overview
Table 102. FibroGen Renal Diseases Drug Product
Table 103. FibroGen Revenue in Renal Diseases Drug Business (2016-2021) & (US$ Million)
Table 104. FibroGen Recent Development
Table 105. Sanofi Company Details
Table 106. Sanofi Business Overview
Table 107. Sanofi Renal Diseases Drug Product
Table 108. Sanofi Revenue in Renal Diseases Drug Business (2016-2021) & (US$ Million)
Table 109. Sanofi Recent Development
Table 110. Teva Pharmaceutical Industries Company Details
Table 111. Teva Pharmaceutical Industries Business Overview
Table 112. Teva Pharmaceutical Industries Renal Diseases Drug Product
Table 113. Teva Pharmaceutical Industries Revenue in Renal Diseases Drug Business (2016-2021) & (US$ Million)
Table 114. Teva Pharmaceutical Industries Recent Development
Table 115. Johnson & Johnson Company Details
Table 116. Johnson & Johnson Business Overview
Table 117. Johnson & Johnson Renal Diseases Drug Product
Table 118. Johnson & Johnson Revenue in Renal Diseases Drug Business (2016-2021) & (US$ Million)
Table 119. Johnson & Johnson Recent Development
Table 120. Keryx Biopharmaceuticals Company Details
Table 121. Keryx Biopharmaceuticals Business Overview
Table 122. Keryx Biopharmaceuticals Renal Diseases Drug Product
Table 123. Keryx Biopharmaceuticals Revenue in Renal Diseases Drug Business (2016-2021) & (US$ Million)
Table 124. Keryx Biopharmaceuticals Recent Development
Table 125. Research Programs/Design for This Report
Table 126. Key Data Information from Secondary Sources
Table 127. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Renal Diseases Drug Market Share by Type: 2020 VS 2027
Figure 2. Chronic Kidney Disease (CKD) Drugs Features
Figure 3. End-Stage Kidney Disease (ESRD) Drugs Features
Figure 4. Global Renal Diseases Drug Market Share by Application: 2020 VS 2027
Figure 5. Hospitals Case Studies
Figure 6. Specialty Clinics Case Studies
Figure 7. Other Case Studies
Figure 8. Renal Diseases Drug Report Years Considered
Figure 9. Global Renal Diseases Drug Market Size (US$ Million), Year-over-Year: 2016-2027
Figure 10. Global Renal Diseases Drug Market Size (US$ Million), 2016 VS 2021 VS 2027
Figure 11. Global Renal Diseases Drug Market Share by Regions: 2020 VS 2027
Figure 12. Global Renal Diseases Drug Market Share by Regions (2022-2027)
Figure 13. Global Renal Diseases Drug Market Share by Players in 2020
Figure 14. Global Top Renal Diseases Drug Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Renal Diseases Drug as of 2020
Figure 15. The Top 10 and 5 Players Market Share by Renal Diseases Drug Revenue in 2020
Figure 16. Global Renal Diseases Drug Revenue Market Share by Type (2016-2021)
Figure 17. Global Renal Diseases Drug Revenue Market Share by Type (2022-2027)
Figure 18. North America Renal Diseases Drug Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 19. North America Renal Diseases Drug Market Share by Type (2016-2027)
Figure 20. North America Renal Diseases Drug Market Share by Application (2016-2027)
Figure 21. North America Renal Diseases Drug Market Share by Country (2016-2027)
Figure 22. United States Renal Diseases Drug Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 23. Canada Renal Diseases Drug Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 24. Europe Renal Diseases Drug Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 25. Europe Renal Diseases Drug Market Share by Type (2016-2027)
Figure 26. Europe Renal Diseases Drug Market Share by Application (2016-2027)
Figure 27. Europe Renal Diseases Drug Market Share by Country (2016-2027)
Figure 28. Germany Renal Diseases Drug Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 29. France Renal Diseases Drug Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 30. U.K. Renal Diseases Drug Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 31. Italy Renal Diseases Drug Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 32. Russia Renal Diseases Drug Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 33. Nordic Renal Diseases Drug Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 34. Asia-Pacific Renal Diseases Drug Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 35. Asia-Pacific Renal Diseases Drug Market Share by Type (2016-2027)
Figure 36. Asia-Pacific Renal Diseases Drug Market Share by Application (2016-2027)
Figure 37. Asia-Pacific Renal Diseases Drug Market Share by Region (2016-2027)
Figure 38. China Renal Diseases Drug Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 39. Japan Renal Diseases Drug Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 40. South Korea Renal Diseases Drug Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 41. Southeast Asia Renal Diseases Drug Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 42. India Renal Diseases Drug Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 43. Australia Renal Diseases Drug Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 44. Latin America Renal Diseases Drug Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 45. Latin America Renal Diseases Drug Market Share by Type (2016-2027)
Figure 46. Latin America Renal Diseases Drug Market Share by Application (2016-2027)
Figure 47. Latin America Renal Diseases Drug Market Share by Country (2016-2027)
Figure 48. Mexico Renal Diseases Drug Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 49. Brazil Renal Diseases Drug Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 50. Middle East & Africa Renal Diseases Drug Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 51. Middle East & Africa Renal Diseases Drug Market Share by Type (2016-2027)
Figure 52. Middle East & Africa Renal Diseases Drug Market Share by Application (2016-2027)
Figure 53. Middle East & Africa Renal Diseases Drug Market Share by Country (2016-2027)
Figure 54. Turkey Renal Diseases Drug Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 55. Saudi Arabia Renal Diseases Drug Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 56. UAE Renal Diseases Drug Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 57. Pfizer Revenue Growth Rate in Renal Diseases Drug Business (2016-2021)
Figure 58. Amgen Revenue Growth Rate in Renal Diseases Drug Business (2016-2021)
Figure 59. Roche Revenue Growth Rate in Renal Diseases Drug Business (2016-2021)
Figure 60. GlaxoSmithKline (GSK) Revenue Growth Rate in Renal Diseases Drug Business (2016-2021)
Figure 61. Allergan Revenue Growth Rate in Renal Diseases Drug Business (2016-2021)
Figure 62. AbbVie Revenue Growth Rate in Renal Diseases Drug Business (2016-2021)
Figure 63. Kissei Pharmaceutical Revenue Growth Rate in Renal Diseases Drug Business (2016-2021)
Figure 64. AstraZeneca Revenue Growth Rate in Renal Diseases Drug Business (2016-2021)
Figure 65. FibroGen Revenue Growth Rate in Renal Diseases Drug Business (2016-2021)
Figure 66. Sanofi Revenue Growth Rate in Renal Diseases Drug Business (2016-2021)
Figure 67. Teva Pharmaceutical Industries Revenue Growth Rate in Renal Diseases Drug Business (2016-2021)
Figure 68. Johnson & Johnson Revenue Growth Rate in Renal Diseases Drug Business (2016-2021)
Figure 69. Keryx Biopharmaceuticals Revenue Growth Rate in Renal Diseases Drug Business (2016-2021)
Figure 70. Bottom-up and Top-down Approaches for This Report
Figure 71. Data Triangulation
Figure 72. Key Executives Interviewed
Keyplayers in Global Renal Diseases Drug Market Size, Status and Forecast 2021-2027
PfizerAmgen
Roche
GlaxoSmithKline (GSK)
Allergan
AbbVie
Kissei Pharmaceutical
AstraZeneca
FibroGen
Sanofi
Teva Pharmaceutical Industries
Johnson & Johnson
Keryx Biopharmaceuticals